Tau haplotype influences cerebral perfusion pattern in frontotemporal lobar degeneration and related disorders

Acta Neurologica Scandinavica

Volumn 117, Issue 5, 2008, Pages 359-366

  Borroni, B ^a,f   Perani, D ^b   Agosti, C ^a   Anchisi, D ^c   Paghera, B ^d   Archetti, S ^a   Alberici, A ^a   Di Luca, M ^e   Padovani, A ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d Brescia Civic Hospital   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

^f UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Cerebrospinal fluid; Frontotemporal lobar degeneration; Principal component analysis; Single photon emission tomography; Statistical parametric mapping; Tau haplotype

Indexed keywords

TAU PROTEIN;

ADULT; AGED; ARTICLE; BRAIN PERFUSION; BRAIN REGION; CEREBROSPINAL FLUID; CINGULATE GYRUS; CLINICAL ARTICLE; FEMALE; FRONTAL CORTEX; FRONTOTEMPORAL LOBAR DEGENERATION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MALE; NERVE DEGENERATION; NEUROMODULATION; NEUROPSYCHOLOGICAL TEST; PARIETAL LOBE; PHENOTYPE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; DEMENTIA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEUROPSYCHOLOGICAL TESTS; POLYMORPHISM, GENETIC; PRINCIPAL COMPONENT ANALYSIS; SEVERITY OF ILLNESS INDEX; TAU PROTEINS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 41849125960     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2007.00955.x     Document Type: Article

References (32)

1. Spillantini MG, Goedert M. Tau protein pathology in neurodegenerative diseases. Trends Neurosci 1998 21 : 428 33.
2. Goedert M, Spillantini MG. Tau gene mutations and neurodegeneration. Biochem Soc Symp 2001 67 : 59 71.
3. Hodges JR, Davies RR, Xuereb JH et al. Clinicopathological correlates in frontotemporal dementia. Ann Neurol 2004 56 : 399 406.
4. Mckhann GM, Albert MS, Grossman M et al. Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. Arch Neurol 2001 58 : 1803 9.
5. Kertesz A. Pick complex: an integrative approach to frontotemporal dementia: primary progressive aphasia, corticobasal degeneration, and progressive supranuclear palsy. Neurologist 2003 9 : 311 7.
6. Strong MJ, Lomen-Hoerth C, Caselli RJ, Bigio EH, Yang W. Cognitive impairment, frontotemporal dementia, and the motor neuron diseases. Ann Neurol 2003 54 : S20 3.
7. Miller BL, Diehl J, Freedman M, Kertesz A, Mendez M, Rascovsky K. International approaches to frontotemporal dementia diagnosis: from social cognition to neuropsychology. Ann Neurol 2003 54 : S7 10.
8. Gorno-Tempini ML, Dronkers NF, Rankin KP et al. Cognition and anatomy in three variants of primary progressive aphasia. Ann Neurol 2004 55 : 335 46.
9. Franceschi M, Anchisi D, Pelati O et al. Glucose metabolism and serotonin receptors in the frontotemporal lobe degeneration. Ann Neurol 2005 57 : 216 25.
10. Salmon E, Garraux G, Delbeuck X et al. Predominant ventromedial frontopolar metabolic impairment in frontotemporal dementia. Neuroimage 2003 20 : 435 40.
11. Kertesz A, Munoz DG. Pick's disease and Pick complex. New York : Wiley-Liss, 1998.
12. Kwok JB, Teber ET, Loy C et al. Tau haplotypes regulate transcription and are associated with Parkinson's disease. Ann Neurol 2004 55 : 329 34.
13. Neary D, Snowden JS, Gustafson L et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998 51 : 1546 54.
14. Litvan I, Agid Y, Calne D et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 1996 47 : 1 9.
15. Lantos PL. Diagnostic criteria for corticobasal degeneration. J Neurol Neurosurg Psychiatry 2000 69 : 705 6.
16. Verpillat P, Ricard S, Hannequin D et al. Is the saitohin gene involved in neurodegenerative diseases? Ann Neurol 2002 52 : 829 32.
17. Rimenschneider M, Wagenpfeil S, Diehl J et al. Tau and Abeta42 protein in CSF of patients with frontotemporal degeneration. Neurology 2002 58 : 1622 8.
18. Friston KJ. Testing for anatomically specified regional effects. Hum Brain Mapp 1997 5 : 133 6.
19. Zuendorf G, Kerrouche N, Herholz C, Baron JC. Efficient principal component analysis for multivariate 3D voxel-based mapping of brain functional imaging data sets as applied to FDG-PET and normal aging. Hum Brain Mapp 2003 18 : 13 21.
20. Conrad C, Vianna C, Schultz C et al. Molecular evolution and genetics of the Saitohin gene and tau haplotype in Alzheimer's disease and argyrophilic grain disease. J Neurochem 2004 89 : 179 88.
21. Houlden H, Baker M, Adamson J et al. Frequency of tau mutations in three series of non-Alzheimer' degenerative dementia. Ann Neurol 1999 46 : 243 8.
22. Sobrido MJ, Miller BL, Havlioglu N et al. Novel tau polymorphisms, tau haplotypes, and splicing in familial and sporadic frontotemporal dementia. Arch Neurol 2003 60 : 698 702.
23. Bugiani O. FTLDP-17: phenotypical heterogeneity within P301S. Ann Neurol 2000 48 : 126.
24. Borroni B, Yancopoulou D, Tsutsui M et al. Association between tau H2 haplotype and age at onset in frontotemporal dementia. Arch Neurol 2005 62 : 1419 22.
25. Liu WK, Le TV, Adamson J et al. Relationship of the extended tau haplotype to tau biochemistry and neuropathology in progressive supranuclear palsy. Ann Neurol 2001 50 : 494 502.
26. Houlden H, Baker M, Morris HR et al. Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology 2001 56 : 1702 6.
27. Baba Y, Tsuboi Y, Baker MC et al. The effect of tau genotype on clinical features in FTDP-17. Parkinsonism Relat Disord 2005 11 : 205 8.
28. Grossman M, Farmer J, Leight S et al. Cerebrospinal fluid profile in frontotemporal dementia and Alzheimer's disease. Ann Neurol 2005 57 : 721 9.
29. Zhukareva V, Vogelsberg-Ragaglia V, Van Deerlin VM et al. Loss of brain tau defines novel sporadic and familial tauopathies with frontotemporal dementia. Ann Neurol 2001 49 : 165 75.
30. Baker M, Mackenzie IR, Pickering-Brown SM et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 2006 442 : 916 9.
31. Cruts M, Gijselinck I, Van Der Zee J et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature 2006 442 : 920 4.
32. Rosen HJ, Hartikainen KM, Jagust W et al. Utility of clinical criteria in differentiating frontotemporal lobar degeneration (FTLD) from AD. Neurology 2002 58 : 1608 15.